Pharmaco - Press Releases

Date	Title	Company
29-Aug-2023	Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall	Dermapharm Holding SE
29-Aug-2023	Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)	Formycon AG
29-Aug-2023	Evotec SE reports results for the first half-year 2023 and provides corporate updates	Evotec SE
28-Aug-2023	Uni-Bio Science Group Limited Announces 2023 Interim Results	UNI-BIO SCIENCE GROUP LIMITED
28-Aug-2023	T-CURX GmbH Announces Appointment of Two Industry Leaders to its Board of Directors	B3C newswire
25-Aug-2023	Kinarus Therapeutics signed licensing agreement to extend cash for operations	Kinarus Therapeutics Holding AG
25-Aug-2023	ABPI response to Journal of Royal Society of Medicine report on Innovative Medicines Fund	ABPI
25-Aug-2023	Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis	B3C newswire
24-Aug-2023	Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023	Evolva Holding SA
24-Aug-2023	Asklepios Kliniken: Stable development in H1 2023 despite challenging market environment	Asklepios Kliniken
24-Aug-2023	Vicore Pharma - Interim report April-June 2023	Vicore Pharma
24-Aug-2023	Douglas GmbH: DOUGLAS continues sales and profit growth in third quarter	Douglas GmbH
24-Aug-2023	Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges	Evolva Holding SA
23-Aug-2023	Abivax appoints Patrick Malloy as Senior Vice President Investor Relations	ABIVAX
23-Aug-2023	KADANS SCIENCE PARTNER WELCOMES AVIADOBIO TO NEW LIFE SCIENCES INNOVATION CENTRE AT CANARY WHARF	Kadans
23-Aug-2023	Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies	Cell and Gene Therapy Catapult (CGT Catapult)
23-Aug-2023	Formycon hosts conference call on financial and earnings position for H1 2023	Formycon AG
22-Aug-2023	Evotec SE reports first half-year 2023 results on 29 August 2023	Evotec SE
22-Aug-2023	PAION launches Byfavo® (remimazolam) in the first European country for General Anesthesia	PAION AG
22-Aug-2023	Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland	Mainz BioMed N.V.